Publication | Closed Access

The α-glucosidase inhibitor miglitol delays the development of diabetes and dysfunctional insulin secretion in pancreatic β-cells in OLETF rats

Pancreatic β-CellsMetabolic Syndromeα-Glucosidase Inhibitor MiglitolInsulin SignalingMedicineInsulin ManagementPhysiologyDiabetesDiabetes MellitusEndocrinologyPharmacologyOletf RatsCell SignalingHealth Sciences